It powers our purpose, drives delivery of our strategy and helps make GSK a place where people can thrive. Our culture of being ambitious for patients, accountable for impact and doing the …

We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas - respiratory, immunology and inflammation; oncology; HIV; and infectious …

Jan 19, 2022 · For detail see gsk.com – onsumer Healthcare capital markets day in February 2022 highlighted our strategic priorities, key C growth drivers and detailed financial information.

Join thousands of outstanding committed GSK people around the world and put your name to The Code. I will live by our Code every day. Our policies and standards support the commitments …

GSK has been ranked 1st in the Access to Medicine Index and achieved a remarkable 2nd position in the pharmaceuticals industry according to the S&P Global Corporate Sustainability …

GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. [3][4] It was …

GSK Consumer Healthcare Subject GlaxoSmithKline Pharmaceuticals Ltd. is studied in terms of its stp, swot analysis and competitors along with tagline, USP and sector.

Myelofibrosis is a rare blood cancer affecting 25,000 in the U.S., causing bone marrow scarring. Ben Schwartz, VP of Oncology, shares his 20-year GSK journey, from drug discovery to …

Jun 23, 2021 · At an update to investors today, GlaxoSmithKline plc (GSK LSE & NYSE) will provide details of its strategy, outlook for growth and plans to create shareholder value, …

Jul 8, 2021 · GlaxoSmithKline (GSK) is looking to “close-in” on untapped potential to grow market share by differentiating itself from the “cold” and functional messaging prevalent in the …